IMBXInvestor Events•businesswire•
Iambic to Participate in September Investor Conferences
Sentiment:Negative (25)
Summary
(IMBX) SAN DIEGO--(BUSINESS WIRE)--Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced its participation in the following September investor conferences: Cantor Global Healthcare Conference - Sept. 3-5, 2025 Citi Global TMT Conference - Sept. 3-5, 2025 Bank of America Healthcare Trailblazers - Sept. 17, 2025 About Iambic’s AI-Driven Discovery Platform The Iambic AI-driven platform w
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 2, 2025 by businesswire